nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—CYP2C19—Sorafenib—liver cancer	0.104	0.261	CbGbCtD
Bicalutamide—CYP2C9—Sorafenib—liver cancer	0.0862	0.217	CbGbCtD
Bicalutamide—CYP2D6—Sorafenib—liver cancer	0.0788	0.198	CbGbCtD
Bicalutamide—CYP3A4—Sorafenib—liver cancer	0.0501	0.126	CbGbCtD
Bicalutamide—CYP2D6—Doxorubicin—liver cancer	0.0478	0.12	CbGbCtD
Bicalutamide—CYP3A4—Doxorubicin—liver cancer	0.0304	0.0766	CbGbCtD
Bicalutamide—Enzalutamide—ALB—liver cancer	0.00277	1	CrCbGaD
Bicalutamide—Sepsis—Epirubicin—liver cancer	0.000983	0.00221	CcSEcCtD
Bicalutamide—Dyspnoea—Sorafenib—liver cancer	0.000974	0.00219	CcSEcCtD
Bicalutamide—Cramps of lower extremities—Doxorubicin—liver cancer	0.000962	0.00217	CcSEcCtD
Bicalutamide—Dyspepsia—Sorafenib—liver cancer	0.000962	0.00216	CcSEcCtD
Bicalutamide—Decreased appetite—Sorafenib—liver cancer	0.00095	0.00214	CcSEcCtD
Bicalutamide—Thrombophlebitis—Epirubicin—liver cancer	0.000949	0.00214	CcSEcCtD
Bicalutamide—Neoplasm—Doxorubicin—liver cancer	0.000947	0.00213	CcSEcCtD
Bicalutamide—Ecchymosis—Doxorubicin—liver cancer	0.000947	0.00213	CcSEcCtD
Bicalutamide—Diabetes mellitus—Epirubicin—liver cancer	0.000945	0.00213	CcSEcCtD
Bicalutamide—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.000945	0.00213	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Sorafenib—liver cancer	0.000944	0.00212	CcSEcCtD
Bicalutamide—Fatigue—Sorafenib—liver cancer	0.000942	0.00212	CcSEcCtD
Bicalutamide—Pain—Sorafenib—liver cancer	0.000935	0.0021	CcSEcCtD
Bicalutamide—Constipation—Sorafenib—liver cancer	0.000935	0.0021	CcSEcCtD
Bicalutamide—Hypertonia—Doxorubicin—liver cancer	0.000918	0.00207	CcSEcCtD
Bicalutamide—Hepatic failure—Epirubicin—liver cancer	0.000915	0.00206	CcSEcCtD
Bicalutamide—Abnormal vision—Doxorubicin—liver cancer	0.000914	0.00206	CcSEcCtD
Bicalutamide—Sepsis—Doxorubicin—liver cancer	0.000909	0.00205	CcSEcCtD
Bicalutamide—Cardiac failure congestive—Epirubicin—liver cancer	0.000906	0.00204	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Sorafenib—liver cancer	0.000894	0.00201	CcSEcCtD
Bicalutamide—Hot flush—Epirubicin—liver cancer	0.000879	0.00198	CcSEcCtD
Bicalutamide—Thrombophlebitis—Doxorubicin—liver cancer	0.000878	0.00198	CcSEcCtD
Bicalutamide—Diabetes mellitus—Doxorubicin—liver cancer	0.000874	0.00197	CcSEcCtD
Bicalutamide—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.000874	0.00197	CcSEcCtD
Bicalutamide—Menopausal symptoms—Epirubicin—liver cancer	0.000871	0.00196	CcSEcCtD
Bicalutamide—Urticaria—Sorafenib—liver cancer	0.000868	0.00195	CcSEcCtD
Bicalutamide—Body temperature increased—Sorafenib—liver cancer	0.000864	0.00194	CcSEcCtD
Bicalutamide—Abdominal pain—Sorafenib—liver cancer	0.000864	0.00194	CcSEcCtD
Bicalutamide—Hepatic failure—Doxorubicin—liver cancer	0.000846	0.0019	CcSEcCtD
Bicalutamide—Hypoglycaemia—Epirubicin—liver cancer	0.000842	0.00189	CcSEcCtD
Bicalutamide—Cardiac failure—Epirubicin—liver cancer	0.000842	0.00189	CcSEcCtD
Bicalutamide—Cerebrovascular accident—Epirubicin—liver cancer	0.000839	0.00189	CcSEcCtD
Bicalutamide—Cardiac failure congestive—Doxorubicin—liver cancer	0.000839	0.00189	CcSEcCtD
Bicalutamide—Hot flush—Doxorubicin—liver cancer	0.000813	0.00183	CcSEcCtD
Bicalutamide—Menopausal symptoms—Doxorubicin—liver cancer	0.000806	0.00181	CcSEcCtD
Bicalutamide—Hypersensitivity—Sorafenib—liver cancer	0.000805	0.00181	CcSEcCtD
Bicalutamide—Face oedema—Epirubicin—liver cancer	0.000793	0.00179	CcSEcCtD
Bicalutamide—Asthenia—Sorafenib—liver cancer	0.000784	0.00176	CcSEcCtD
Bicalutamide—Cardiac arrest—Epirubicin—liver cancer	0.000781	0.00176	CcSEcCtD
Bicalutamide—Cardiac failure—Doxorubicin—liver cancer	0.000779	0.00175	CcSEcCtD
Bicalutamide—Hypoglycaemia—Doxorubicin—liver cancer	0.000779	0.00175	CcSEcCtD
Bicalutamide—Cerebrovascular accident—Doxorubicin—liver cancer	0.000776	0.00175	CcSEcCtD
Bicalutamide—Pruritus—Sorafenib—liver cancer	0.000773	0.00174	CcSEcCtD
Bicalutamide—Blood creatinine increased—Epirubicin—liver cancer	0.00077	0.00173	CcSEcCtD
Bicalutamide—Dehydration—Epirubicin—liver cancer	0.000764	0.00172	CcSEcCtD
Bicalutamide—Liver function test abnormal—Epirubicin—liver cancer	0.000759	0.00171	CcSEcCtD
Bicalutamide—Dry skin—Epirubicin—liver cancer	0.000753	0.00169	CcSEcCtD
Bicalutamide—Diarrhoea—Sorafenib—liver cancer	0.000748	0.00168	CcSEcCtD
Bicalutamide—Breast disorder—Epirubicin—liver cancer	0.000743	0.00167	CcSEcCtD
Bicalutamide—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00074	0.00166	CcSEcCtD
Bicalutamide—Face oedema—Doxorubicin—liver cancer	0.000734	0.00165	CcSEcCtD
Bicalutamide—Gastritis—Epirubicin—liver cancer	0.000727	0.00164	CcSEcCtD
Bicalutamide—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000725	0.00163	CcSEcCtD
Bicalutamide—Muscular weakness—Epirubicin—liver cancer	0.000725	0.00163	CcSEcCtD
Bicalutamide—Cardiac arrest—Doxorubicin—liver cancer	0.000723	0.00163	CcSEcCtD
Bicalutamide—Dizziness—Sorafenib—liver cancer	0.000723	0.00163	CcSEcCtD
Bicalutamide—Blood creatinine increased—Doxorubicin—liver cancer	0.000712	0.0016	CcSEcCtD
Bicalutamide—Dysphagia—Epirubicin—liver cancer	0.00071	0.0016	CcSEcCtD
Bicalutamide—Influenza—Epirubicin—liver cancer	0.00071	0.0016	CcSEcCtD
Bicalutamide—Asthma—Epirubicin—liver cancer	0.00071	0.0016	CcSEcCtD
Bicalutamide—Dehydration—Doxorubicin—liver cancer	0.000707	0.00159	CcSEcCtD
Bicalutamide—Eosinophilia—Epirubicin—liver cancer	0.000703	0.00158	CcSEcCtD
Bicalutamide—Liver function test abnormal—Doxorubicin—liver cancer	0.000702	0.00158	CcSEcCtD
Bicalutamide—Dry skin—Doxorubicin—liver cancer	0.000697	0.00157	CcSEcCtD
Bicalutamide—Vomiting—Sorafenib—liver cancer	0.000695	0.00156	CcSEcCtD
Bicalutamide—Angina pectoris—Epirubicin—liver cancer	0.000692	0.00156	CcSEcCtD
Bicalutamide—Rash—Sorafenib—liver cancer	0.000689	0.00155	CcSEcCtD
Bicalutamide—Dermatitis—Sorafenib—liver cancer	0.000689	0.00155	CcSEcCtD
Bicalutamide—Breast disorder—Doxorubicin—liver cancer	0.000687	0.00155	CcSEcCtD
Bicalutamide—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000685	0.00154	CcSEcCtD
Bicalutamide—Headache—Sorafenib—liver cancer	0.000685	0.00154	CcSEcCtD
Bicalutamide—Bronchitis—Epirubicin—liver cancer	0.000683	0.00154	CcSEcCtD
Bicalutamide—Gastritis—Doxorubicin—liver cancer	0.000673	0.00151	CcSEcCtD
Bicalutamide—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000671	0.00151	CcSEcCtD
Bicalutamide—Muscular weakness—Doxorubicin—liver cancer	0.000671	0.00151	CcSEcCtD
Bicalutamide—Neutropenia—Epirubicin—liver cancer	0.000664	0.00149	CcSEcCtD
Bicalutamide—Dysuria—Epirubicin—liver cancer	0.000664	0.00149	CcSEcCtD
Bicalutamide—Asthma—Doxorubicin—liver cancer	0.000657	0.00148	CcSEcCtD
Bicalutamide—Influenza—Doxorubicin—liver cancer	0.000657	0.00148	CcSEcCtD
Bicalutamide—Dysphagia—Doxorubicin—liver cancer	0.000657	0.00148	CcSEcCtD
Bicalutamide—Pollakiuria—Epirubicin—liver cancer	0.000656	0.00148	CcSEcCtD
Bicalutamide—Eosinophilia—Doxorubicin—liver cancer	0.000651	0.00146	CcSEcCtD
Bicalutamide—Nausea—Sorafenib—liver cancer	0.000649	0.00146	CcSEcCtD
Bicalutamide—Weight increased—Epirubicin—liver cancer	0.000646	0.00145	CcSEcCtD
Bicalutamide—Weight decreased—Epirubicin—liver cancer	0.000643	0.00145	CcSEcCtD
Bicalutamide—Hyperglycaemia—Epirubicin—liver cancer	0.000641	0.00144	CcSEcCtD
Bicalutamide—Angina pectoris—Doxorubicin—liver cancer	0.00064	0.00144	CcSEcCtD
Bicalutamide—Pneumonia—Epirubicin—liver cancer	0.000637	0.00143	CcSEcCtD
Bicalutamide—Bronchitis—Doxorubicin—liver cancer	0.000632	0.00142	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Epirubicin—liver cancer	0.000621	0.0014	CcSEcCtD
Bicalutamide—Jaundice—Epirubicin—liver cancer	0.000617	0.00139	CcSEcCtD
Bicalutamide—Urinary tract infection—Epirubicin—liver cancer	0.000616	0.00139	CcSEcCtD
Bicalutamide—Conjunctivitis—Epirubicin—liver cancer	0.000616	0.00139	CcSEcCtD
Bicalutamide—Neutropenia—Doxorubicin—liver cancer	0.000615	0.00138	CcSEcCtD
Bicalutamide—Dysuria—Doxorubicin—liver cancer	0.000615	0.00138	CcSEcCtD
Bicalutamide—Sweating—Epirubicin—liver cancer	0.000607	0.00137	CcSEcCtD
Bicalutamide—Pollakiuria—Doxorubicin—liver cancer	0.000607	0.00137	CcSEcCtD
Bicalutamide—Haematuria—Epirubicin—liver cancer	0.000604	0.00136	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Epirubicin—liver cancer	0.000599	0.00135	CcSEcCtD
Bicalutamide—Weight increased—Doxorubicin—liver cancer	0.000598	0.00135	CcSEcCtD
Bicalutamide—Epistaxis—Epirubicin—liver cancer	0.000597	0.00134	CcSEcCtD
Bicalutamide—Weight decreased—Doxorubicin—liver cancer	0.000595	0.00134	CcSEcCtD
Bicalutamide—Sinusitis—Epirubicin—liver cancer	0.000594	0.00134	CcSEcCtD
Bicalutamide—Hyperglycaemia—Doxorubicin—liver cancer	0.000593	0.00133	CcSEcCtD
Bicalutamide—Pneumonia—Doxorubicin—liver cancer	0.000589	0.00133	CcSEcCtD
Bicalutamide—Bradycardia—Epirubicin—liver cancer	0.000579	0.0013	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Doxorubicin—liver cancer	0.000574	0.00129	CcSEcCtD
Bicalutamide—Haemoglobin—Epirubicin—liver cancer	0.000571	0.00129	CcSEcCtD
Bicalutamide—Jaundice—Doxorubicin—liver cancer	0.000571	0.00129	CcSEcCtD
Bicalutamide—Rhinitis—Epirubicin—liver cancer	0.00057	0.00128	CcSEcCtD
Bicalutamide—Urinary tract infection—Doxorubicin—liver cancer	0.00057	0.00128	CcSEcCtD
Bicalutamide—Conjunctivitis—Doxorubicin—liver cancer	0.00057	0.00128	CcSEcCtD
Bicalutamide—Haemorrhage—Epirubicin—liver cancer	0.000569	0.00128	CcSEcCtD
Bicalutamide—Pharyngitis—Epirubicin—liver cancer	0.000564	0.00127	CcSEcCtD
Bicalutamide—Sweating—Doxorubicin—liver cancer	0.000562	0.00126	CcSEcCtD
Bicalutamide—Urinary tract disorder—Epirubicin—liver cancer	0.000561	0.00126	CcSEcCtD
Bicalutamide—Oedema peripheral—Epirubicin—liver cancer	0.00056	0.00126	CcSEcCtD
Bicalutamide—Haematuria—Doxorubicin—liver cancer	0.000559	0.00126	CcSEcCtD
Bicalutamide—Urethral disorder—Epirubicin—liver cancer	0.000557	0.00125	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Doxorubicin—liver cancer	0.000554	0.00125	CcSEcCtD
Bicalutamide—Epistaxis—Doxorubicin—liver cancer	0.000553	0.00124	CcSEcCtD
Bicalutamide—Sinusitis—Doxorubicin—liver cancer	0.00055	0.00124	CcSEcCtD
Bicalutamide—Visual impairment—Epirubicin—liver cancer	0.000548	0.00123	CcSEcCtD
Bicalutamide—Bradycardia—Doxorubicin—liver cancer	0.000536	0.0012	CcSEcCtD
Bicalutamide—Haemoglobin—Doxorubicin—liver cancer	0.000529	0.00119	CcSEcCtD
Bicalutamide—Cardiac disorder—Epirubicin—liver cancer	0.000528	0.00119	CcSEcCtD
Bicalutamide—Rhinitis—Doxorubicin—liver cancer	0.000527	0.00119	CcSEcCtD
Bicalutamide—Haemorrhage—Doxorubicin—liver cancer	0.000526	0.00118	CcSEcCtD
Bicalutamide—Pharyngitis—Doxorubicin—liver cancer	0.000522	0.00117	CcSEcCtD
Bicalutamide—Urinary tract disorder—Doxorubicin—liver cancer	0.00052	0.00117	CcSEcCtD
Bicalutamide—Oedema peripheral—Doxorubicin—liver cancer	0.000518	0.00117	CcSEcCtD
Bicalutamide—Angiopathy—Epirubicin—liver cancer	0.000516	0.00116	CcSEcCtD
Bicalutamide—Urethral disorder—Doxorubicin—liver cancer	0.000516	0.00116	CcSEcCtD
Bicalutamide—Immune system disorder—Epirubicin—liver cancer	0.000514	0.00116	CcSEcCtD
Bicalutamide—Mediastinal disorder—Epirubicin—liver cancer	0.000512	0.00115	CcSEcCtD
Bicalutamide—Chills—Epirubicin—liver cancer	0.00051	0.00115	CcSEcCtD
Bicalutamide—Arrhythmia—Epirubicin—liver cancer	0.000508	0.00114	CcSEcCtD
Bicalutamide—Visual impairment—Doxorubicin—liver cancer	0.000507	0.00114	CcSEcCtD
Bicalutamide—Alopecia—Epirubicin—liver cancer	0.000502	0.00113	CcSEcCtD
Bicalutamide—Mental disorder—Epirubicin—liver cancer	0.000498	0.00112	CcSEcCtD
Bicalutamide—Malnutrition—Epirubicin—liver cancer	0.000495	0.00111	CcSEcCtD
Bicalutamide—Cardiac disorder—Doxorubicin—liver cancer	0.000488	0.0011	CcSEcCtD
Bicalutamide—Flatulence—Epirubicin—liver cancer	0.000488	0.0011	CcSEcCtD
Bicalutamide—Tension—Epirubicin—liver cancer	0.000486	0.00109	CcSEcCtD
Bicalutamide—Nervousness—Epirubicin—liver cancer	0.000481	0.00108	CcSEcCtD
Bicalutamide—Back pain—Epirubicin—liver cancer	0.000479	0.00108	CcSEcCtD
Bicalutamide—Angiopathy—Doxorubicin—liver cancer	0.000477	0.00107	CcSEcCtD
Bicalutamide—Muscle spasms—Epirubicin—liver cancer	0.000476	0.00107	CcSEcCtD
Bicalutamide—Immune system disorder—Doxorubicin—liver cancer	0.000475	0.00107	CcSEcCtD
Bicalutamide—Mediastinal disorder—Doxorubicin—liver cancer	0.000474	0.00107	CcSEcCtD
Bicalutamide—Chills—Doxorubicin—liver cancer	0.000472	0.00106	CcSEcCtD
Bicalutamide—Arrhythmia—Doxorubicin—liver cancer	0.00047	0.00106	CcSEcCtD
Bicalutamide—Alopecia—Doxorubicin—liver cancer	0.000465	0.00105	CcSEcCtD
Bicalutamide—Mental disorder—Doxorubicin—liver cancer	0.000461	0.00104	CcSEcCtD
Bicalutamide—Malnutrition—Doxorubicin—liver cancer	0.000458	0.00103	CcSEcCtD
Bicalutamide—Anaemia—Epirubicin—liver cancer	0.000457	0.00103	CcSEcCtD
Bicalutamide—Flatulence—Doxorubicin—liver cancer	0.000451	0.00102	CcSEcCtD
Bicalutamide—Tension—Doxorubicin—liver cancer	0.000449	0.00101	CcSEcCtD
Bicalutamide—Nervousness—Doxorubicin—liver cancer	0.000445	0.001	CcSEcCtD
Bicalutamide—Syncope—Epirubicin—liver cancer	0.000444	0.000999	CcSEcCtD
Bicalutamide—Back pain—Doxorubicin—liver cancer	0.000443	0.000997	CcSEcCtD
Bicalutamide—Muscle spasms—Doxorubicin—liver cancer	0.00044	0.000991	CcSEcCtD
Bicalutamide—Loss of consciousness—Epirubicin—liver cancer	0.000435	0.000979	CcSEcCtD
Bicalutamide—Cough—Epirubicin—liver cancer	0.000432	0.000972	CcSEcCtD
Bicalutamide—Hypertension—Epirubicin—liver cancer	0.000427	0.000961	CcSEcCtD
Bicalutamide—Anaemia—Doxorubicin—liver cancer	0.000423	0.000952	CcSEcCtD
Bicalutamide—Chest pain—Epirubicin—liver cancer	0.000421	0.000948	CcSEcCtD
Bicalutamide—Myalgia—Epirubicin—liver cancer	0.000421	0.000948	CcSEcCtD
Bicalutamide—Anxiety—Epirubicin—liver cancer	0.00042	0.000945	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000418	0.000941	CcSEcCtD
Bicalutamide—Dry mouth—Epirubicin—liver cancer	0.000412	0.000927	CcSEcCtD
Bicalutamide—Syncope—Doxorubicin—liver cancer	0.000411	0.000924	CcSEcCtD
Bicalutamide—Confusional state—Epirubicin—liver cancer	0.000407	0.000916	CcSEcCtD
Bicalutamide—Oedema—Epirubicin—liver cancer	0.000404	0.000909	CcSEcCtD
Bicalutamide—Loss of consciousness—Doxorubicin—liver cancer	0.000403	0.000906	CcSEcCtD
Bicalutamide—Infection—Epirubicin—liver cancer	0.000401	0.000903	CcSEcCtD
Bicalutamide—Cough—Doxorubicin—liver cancer	0.0004	0.000899	CcSEcCtD
Bicalutamide—Shock—Epirubicin—liver cancer	0.000397	0.000894	CcSEcCtD
Bicalutamide—Nervous system disorder—Epirubicin—liver cancer	0.000396	0.000891	CcSEcCtD
Bicalutamide—Thrombocytopenia—Epirubicin—liver cancer	0.000396	0.00089	CcSEcCtD
Bicalutamide—Hypertension—Doxorubicin—liver cancer	0.000395	0.00089	CcSEcCtD
Bicalutamide—Skin disorder—Epirubicin—liver cancer	0.000392	0.000883	CcSEcCtD
Bicalutamide—Hyperhidrosis—Epirubicin—liver cancer	0.000391	0.000879	CcSEcCtD
Bicalutamide—Myalgia—Doxorubicin—liver cancer	0.00039	0.000877	CcSEcCtD
Bicalutamide—Chest pain—Doxorubicin—liver cancer	0.00039	0.000877	CcSEcCtD
Bicalutamide—Anxiety—Doxorubicin—liver cancer	0.000389	0.000874	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000387	0.000871	CcSEcCtD
Bicalutamide—Anorexia—Epirubicin—liver cancer	0.000385	0.000866	CcSEcCtD
Bicalutamide—Dry mouth—Doxorubicin—liver cancer	0.000381	0.000858	CcSEcCtD
Bicalutamide—Confusional state—Doxorubicin—liver cancer	0.000377	0.000848	CcSEcCtD
Bicalutamide—Oedema—Doxorubicin—liver cancer	0.000374	0.000841	CcSEcCtD
Bicalutamide—Infection—Doxorubicin—liver cancer	0.000371	0.000835	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000368	0.000828	CcSEcCtD
Bicalutamide—Shock—Doxorubicin—liver cancer	0.000368	0.000827	CcSEcCtD
Bicalutamide—Nervous system disorder—Doxorubicin—liver cancer	0.000367	0.000825	CcSEcCtD
Bicalutamide—Thrombocytopenia—Doxorubicin—liver cancer	0.000366	0.000823	CcSEcCtD
Bicalutamide—Insomnia—Epirubicin—liver cancer	0.000365	0.000822	CcSEcCtD
Bicalutamide—Skin disorder—Doxorubicin—liver cancer	0.000363	0.000817	CcSEcCtD
Bicalutamide—Paraesthesia—Epirubicin—liver cancer	0.000363	0.000816	CcSEcCtD
Bicalutamide—Hyperhidrosis—Doxorubicin—liver cancer	0.000361	0.000813	CcSEcCtD
Bicalutamide—Dyspnoea—Epirubicin—liver cancer	0.00036	0.00081	CcSEcCtD
Bicalutamide—Somnolence—Epirubicin—liver cancer	0.000359	0.000808	CcSEcCtD
Bicalutamide—Anorexia—Doxorubicin—liver cancer	0.000356	0.000802	CcSEcCtD
Bicalutamide—Dyspepsia—Epirubicin—liver cancer	0.000356	0.0008	CcSEcCtD
Bicalutamide—Decreased appetite—Epirubicin—liver cancer	0.000351	0.00079	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Epirubicin—liver cancer	0.000349	0.000785	CcSEcCtD
Bicalutamide—Fatigue—Epirubicin—liver cancer	0.000348	0.000783	CcSEcCtD
Bicalutamide—Pain—Epirubicin—liver cancer	0.000345	0.000777	CcSEcCtD
Bicalutamide—Constipation—Epirubicin—liver cancer	0.000345	0.000777	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000341	0.000766	CcSEcCtD
Bicalutamide—Insomnia—Doxorubicin—liver cancer	0.000338	0.000761	CcSEcCtD
Bicalutamide—Paraesthesia—Doxorubicin—liver cancer	0.000336	0.000755	CcSEcCtD
Bicalutamide—Dyspnoea—Doxorubicin—liver cancer	0.000333	0.00075	CcSEcCtD
Bicalutamide—Feeling abnormal—Epirubicin—liver cancer	0.000333	0.000749	CcSEcCtD
Bicalutamide—Somnolence—Doxorubicin—liver cancer	0.000332	0.000748	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Epirubicin—liver cancer	0.00033	0.000743	CcSEcCtD
Bicalutamide—Dyspepsia—Doxorubicin—liver cancer	0.000329	0.00074	CcSEcCtD
Bicalutamide—Decreased appetite—Doxorubicin—liver cancer	0.000325	0.000731	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000323	0.000726	CcSEcCtD
Bicalutamide—Fatigue—Doxorubicin—liver cancer	0.000322	0.000725	CcSEcCtD
Bicalutamide—Urticaria—Epirubicin—liver cancer	0.000321	0.000722	CcSEcCtD
Bicalutamide—Constipation—Doxorubicin—liver cancer	0.00032	0.000719	CcSEcCtD
Bicalutamide—Pain—Doxorubicin—liver cancer	0.00032	0.000719	CcSEcCtD
Bicalutamide—Abdominal pain—Epirubicin—liver cancer	0.000319	0.000718	CcSEcCtD
Bicalutamide—Body temperature increased—Epirubicin—liver cancer	0.000319	0.000718	CcSEcCtD
Bicalutamide—Feeling abnormal—Doxorubicin—liver cancer	0.000308	0.000693	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Doxorubicin—liver cancer	0.000306	0.000688	CcSEcCtD
Bicalutamide—Hypersensitivity—Epirubicin—liver cancer	0.000298	0.00067	CcSEcCtD
Bicalutamide—Urticaria—Doxorubicin—liver cancer	0.000297	0.000668	CcSEcCtD
Bicalutamide—Abdominal pain—Doxorubicin—liver cancer	0.000295	0.000665	CcSEcCtD
Bicalutamide—Body temperature increased—Doxorubicin—liver cancer	0.000295	0.000665	CcSEcCtD
Bicalutamide—Asthenia—Epirubicin—liver cancer	0.00029	0.000652	CcSEcCtD
Bicalutamide—Pruritus—Epirubicin—liver cancer	0.000286	0.000643	CcSEcCtD
Bicalutamide—Diarrhoea—Epirubicin—liver cancer	0.000276	0.000622	CcSEcCtD
Bicalutamide—Hypersensitivity—Doxorubicin—liver cancer	0.000275	0.00062	CcSEcCtD
Bicalutamide—Asthenia—Doxorubicin—liver cancer	0.000268	0.000603	CcSEcCtD
Bicalutamide—Dizziness—Epirubicin—liver cancer	0.000267	0.000601	CcSEcCtD
Bicalutamide—Pruritus—Doxorubicin—liver cancer	0.000264	0.000595	CcSEcCtD
Bicalutamide—Vomiting—Epirubicin—liver cancer	0.000257	0.000578	CcSEcCtD
Bicalutamide—Diarrhoea—Doxorubicin—liver cancer	0.000256	0.000575	CcSEcCtD
Bicalutamide—Rash—Epirubicin—liver cancer	0.000255	0.000573	CcSEcCtD
Bicalutamide—Dermatitis—Epirubicin—liver cancer	0.000254	0.000572	CcSEcCtD
Bicalutamide—Headache—Epirubicin—liver cancer	0.000253	0.000569	CcSEcCtD
Bicalutamide—Dizziness—Doxorubicin—liver cancer	0.000247	0.000556	CcSEcCtD
Bicalutamide—Nausea—Epirubicin—liver cancer	0.00024	0.00054	CcSEcCtD
Bicalutamide—Vomiting—Doxorubicin—liver cancer	0.000238	0.000535	CcSEcCtD
Bicalutamide—Rash—Doxorubicin—liver cancer	0.000236	0.00053	CcSEcCtD
Bicalutamide—Dermatitis—Doxorubicin—liver cancer	0.000235	0.00053	CcSEcCtD
Bicalutamide—Headache—Doxorubicin—liver cancer	0.000234	0.000527	CcSEcCtD
Bicalutamide—Nausea—Doxorubicin—liver cancer	0.000222	0.000499	CcSEcCtD
Bicalutamide—AR—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000197	0.00126	CbGpPWpGaD
Bicalutamide—CYP2C19—Metapathway biotransformation—CYP2E1—liver cancer	0.000196	0.00126	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000195	0.00125	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000193	0.00124	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000192	0.00124	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—NR1H4—liver cancer	0.000192	0.00123	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—NR1I3—liver cancer	0.000189	0.00121	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	0.000187	0.0012	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000186	0.00119	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000184	0.00118	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—CYP2E1—liver cancer	0.000183	0.00117	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—GGT1—liver cancer	0.000183	0.00117	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—CYP2E1—liver cancer	0.000181	0.00116	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000181	0.00116	CbGpPWpGaD
Bicalutamide—CYP2D6—Metapathway biotransformation—CYP2E1—liver cancer	0.00018	0.00116	CbGpPWpGaD
Bicalutamide—CYP2C9—Metapathway biotransformation—CYP2E1—liver cancer	0.000179	0.00115	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—VEGFA—liver cancer	0.000178	0.00114	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000177	0.00114	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000174	0.00112	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000173	0.00111	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—AKT1—liver cancer	0.000173	0.00111	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000169	0.00109	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000169	0.00108	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—GGT1—liver cancer	0.000168	0.00108	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000167	0.00108	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—GGT1—liver cancer	0.000167	0.00107	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—GSTP1—liver cancer	0.000164	0.00105	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—MYC—liver cancer	0.000164	0.00105	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000164	0.00105	CbGpPWpGaD
Bicalutamide—CYP2C19—Metapathway biotransformation—GSTP1—liver cancer	0.000162	0.00104	CbGpPWpGaD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000162	0.00104	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.00016	0.00103	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000154	0.000988	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—KRAS—liver cancer	0.000151	0.000971	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—GSTP1—liver cancer	0.000151	0.000969	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—GSTM1—liver cancer	0.000151	0.000968	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—GSTP1—liver cancer	0.00015	0.00096	CbGpPWpGaD
Bicalutamide—CYP2D6—Metapathway biotransformation—GSTP1—liver cancer	0.000149	0.000956	CbGpPWpGaD
Bicalutamide—CYP2C19—Metapathway biotransformation—GSTM1—liver cancer	0.000149	0.000955	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—TNF—liver cancer	0.000149	0.000954	CbGpPWpGaD
Bicalutamide—CYP2C9—Metapathway biotransformation—GSTP1—liver cancer	0.000148	0.000947	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.000147	0.000947	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000147	0.000942	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000145	0.000934	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—PPARA—liver cancer	0.000143	0.000918	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—CYP1A1—liver cancer	0.000143	0.000918	CbGpPWpGaD
Bicalutamide—CYP2C19—Metapathway biotransformation—CYP1A1—liver cancer	0.000141	0.000905	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00014	0.0009	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—GSTM1—liver cancer	0.000139	0.00089	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—GSTM1—liver cancer	0.000137	0.000883	CbGpPWpGaD
Bicalutamide—CYP2D6—Metapathway biotransformation—GSTM1—liver cancer	0.000137	0.000878	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000136	0.000871	CbGpPWpGaD
Bicalutamide—CYP2C9—Metapathway biotransformation—GSTM1—liver cancer	0.000136	0.00087	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000135	0.000869	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—TP53—liver cancer	0.000134	0.000863	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000133	0.000851	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—CYP1A1—liver cancer	0.000131	0.000844	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—HNF4A—liver cancer	0.000131	0.000841	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—CYP1A1—liver cancer	0.00013	0.000837	CbGpPWpGaD
Bicalutamide—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	0.00013	0.000832	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—ESR1—liver cancer	0.00013	0.000832	CbGpPWpGaD
Bicalutamide—CYP2C9—Metapathway biotransformation—CYP1A1—liver cancer	0.000129	0.000825	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000128	0.000821	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000126	0.000811	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000125	0.000805	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—IL6—liver cancer	0.00012	0.00077	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.00012	0.000768	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—PPARG—liver cancer	0.000118	0.000759	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000118	0.000758	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000115	0.000739	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—PSMD10—liver cancer	0.000115	0.000736	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—PSMA4—liver cancer	0.000115	0.000736	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—AKT1—liver cancer	0.000114	0.000729	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000111	0.000715	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—GGT1—liver cancer	0.00011	0.000705	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000107	0.000688	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—UGDH—liver cancer	0.000107	0.000686	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—SERPINE1—liver cancer	0.000106	0.000684	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—EPT1—liver cancer	0.000101	0.000645	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—GSTP1—liver cancer	9.87e-05	0.000633	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—UGDH—liver cancer	9.83e-05	0.000631	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	9.78e-05	0.000628	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—UGDH—liver cancer	9.75e-05	0.000626	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	9.73e-05	0.000625	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—TAT—liver cancer	9.53e-05	0.000612	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	9.41e-05	0.000604	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	9.37e-05	0.000602	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—EPT1—liver cancer	9.24e-05	0.000593	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—EPT1—liver cancer	9.16e-05	0.000588	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—GSTM1—liver cancer	9.07e-05	0.000582	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	8.94e-05	0.000574	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—TAT—liver cancer	8.76e-05	0.000563	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—TAT—liver cancer	8.69e-05	0.000558	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—CYP1A1—liver cancer	8.59e-05	0.000552	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	8.54e-05	0.000549	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	8.48e-05	0.000544	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—H2AFX—liver cancer	7.74e-05	0.000497	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	7.01e-05	0.00045	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—PPARA—liver cancer	6.88e-05	0.000442	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—MYC—liver cancer	6.74e-05	0.000433	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CPT1B—liver cancer	6.48e-05	0.000416	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GLUL—liver cancer	6.48e-05	0.000416	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—UGDH—liver cancer	6.43e-05	0.000413	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	6.4e-05	0.000411	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—MAPK14—liver cancer	6.36e-05	0.000408	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NR1H4—liver cancer	6.24e-05	0.000401	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—ESR1—liver cancer	6.24e-05	0.0004	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTA3—liver cancer	6.14e-05	0.000394	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—EPT1—liver cancer	6.04e-05	0.000388	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GLUL—liver cancer	5.96e-05	0.000382	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CPT1B—liver cancer	5.96e-05	0.000382	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CPT1B—liver cancer	5.91e-05	0.000379	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GLUL—liver cancer	5.91e-05	0.000379	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NR1H4—liver cancer	5.74e-05	0.000369	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—TAT—liver cancer	5.73e-05	0.000368	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NR1H4—liver cancer	5.69e-05	0.000366	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—PPARG—liver cancer	5.69e-05	0.000365	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTA3—liver cancer	5.65e-05	0.000363	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTA4—liver cancer	5.62e-05	0.000361	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTA3—liver cancer	5.6e-05	0.000359	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	5.49e-05	0.000352	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTA2—liver cancer	5.47e-05	0.000351	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTA1—liver cancer	5.28e-05	0.000339	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NAT2—liver cancer	5.22e-05	0.000335	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTA4—liver cancer	5.16e-05	0.000332	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—SERPINE1—liver cancer	5.13e-05	0.000329	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTA4—liver cancer	5.12e-05	0.000329	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTA2—liver cancer	5.03e-05	0.000323	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	5.02e-05	0.000322	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALDOB—liver cancer	5e-05	0.000321	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	5e-05	0.000321	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTA2—liver cancer	4.99e-05	0.00032	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTA1—liver cancer	4.86e-05	0.000312	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTA1—liver cancer	4.81e-05	0.000309	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NAT2—liver cancer	4.8e-05	0.000308	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CRABP1—liver cancer	4.77e-05	0.000307	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NAT2—liver cancer	4.76e-05	0.000306	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALDOB—liver cancer	4.6e-05	0.000296	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.58e-05	0.000294	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALDOB—liver cancer	4.56e-05	0.000293	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CRABP1—liver cancer	4.39e-05	0.000282	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CRABP1—liver cancer	4.35e-05	0.00028	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.3e-05	0.000276	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HPGDS—liver cancer	4.17e-05	0.000268	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.15e-05	0.000266	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.92e-05	0.000252	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CPT1B—liver cancer	3.89e-05	0.00025	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GLUL—liver cancer	3.89e-05	0.00025	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HPGDS—liver cancer	3.84e-05	0.000246	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HPGDS—liver cancer	3.81e-05	0.000244	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.78e-05	0.000243	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.78e-05	0.000243	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NR1H4—liver cancer	3.76e-05	0.000241	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.73e-05	0.00024	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PSMD10—liver cancer	3.72e-05	0.000239	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PSMA4—liver cancer	3.72e-05	0.000239	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTA3—liver cancer	3.69e-05	0.000237	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GOT2—liver cancer	3.62e-05	0.000232	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.45e-05	0.000221	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PSMD10—liver cancer	3.42e-05	0.00022	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PSMA4—liver cancer	3.42e-05	0.00022	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP2E1—liver cancer	3.4e-05	0.000218	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.4e-05	0.000218	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PSMA4—liver cancer	3.39e-05	0.000218	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PSMD10—liver cancer	3.39e-05	0.000218	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTA4—liver cancer	3.38e-05	0.000217	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GOT2—liver cancer	3.33e-05	0.000214	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GOT2—liver cancer	3.3e-05	0.000212	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.29e-05	0.000211	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTA2—liver cancer	3.29e-05	0.000211	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—MYC—liver cancer	3.24e-05	0.000208	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYCS—liver cancer	3.18e-05	0.000204	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTA1—liver cancer	3.17e-05	0.000204	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NAT2—liver cancer	3.14e-05	0.000202	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP2E1—liver cancer	3.13e-05	0.000201	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GOT1—liver cancer	3.12e-05	0.000201	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GGT1—liver cancer	3.12e-05	0.000201	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP2E1—liver cancer	3.1e-05	0.000199	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALDOB—liver cancer	3.01e-05	0.000193	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3e-05	0.000193	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYCS—liver cancer	2.93e-05	0.000188	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYCS—liver cancer	2.9e-05	0.000186	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GOT1—liver cancer	2.87e-05	0.000184	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GGT1—liver cancer	2.87e-05	0.000184	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CRABP1—liver cancer	2.87e-05	0.000184	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GGT1—liver cancer	2.85e-05	0.000183	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GOT1—liver cancer	2.85e-05	0.000183	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTP1—liver cancer	2.81e-05	0.00018	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HMOX1—liver cancer	2.77e-05	0.000178	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTP1—liver cancer	2.58e-05	0.000166	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GSTM1—liver cancer	2.58e-05	0.000166	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTP1—liver cancer	2.56e-05	0.000164	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HMOX1—liver cancer	2.55e-05	0.000163	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HMOX1—liver cancer	2.52e-05	0.000162	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HPGDS—liver cancer	2.51e-05	0.000161	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP1A1—liver cancer	2.44e-05	0.000157	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GSTM1—liver cancer	2.37e-05	0.000152	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GSTM1—liver cancer	2.35e-05	0.000151	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—MTHFR—liver cancer	2.28e-05	0.000146	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—AKT1—liver cancer	2.25e-05	0.000144	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP1A1—liver cancer	2.25e-05	0.000144	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PSMD10—liver cancer	2.24e-05	0.000144	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PSMA4—liver cancer	2.24e-05	0.000144	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PPARA—liver cancer	2.24e-05	0.000144	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP1A1—liver cancer	2.23e-05	0.000143	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GOT2—liver cancer	2.18e-05	0.00014	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—MTHFR—liver cancer	2.1e-05	0.000135	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—MTHFR—liver cancer	2.08e-05	0.000133	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PPARA—liver cancer	2.06e-05	0.000132	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP2E1—liver cancer	2.05e-05	0.000131	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PPARA—liver cancer	2.04e-05	0.000131	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.01e-05	0.000129	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CG—liver cancer	1.91e-05	0.000123	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYCS—liver cancer	1.91e-05	0.000123	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GOT1—liver cancer	1.88e-05	0.000121	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GGT1—liver cancer	1.88e-05	0.000121	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PPARG—liver cancer	1.85e-05	0.000119	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.83e-05	0.000118	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CG—liver cancer	1.76e-05	0.000113	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CG—liver cancer	1.75e-05	0.000112	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PPARG—liver cancer	1.7e-05	0.000109	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTP1—liver cancer	1.69e-05	0.000108	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PPARG—liver cancer	1.68e-05	0.000108	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CD—liver cancer	1.68e-05	0.000108	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HMOX1—liver cancer	1.66e-05	0.000107	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALB—liver cancer	1.66e-05	0.000107	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GSTM1—liver cancer	1.55e-05	9.95e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CD—liver cancer	1.55e-05	9.94e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CD—liver cancer	1.53e-05	9.85e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALB—liver cancer	1.53e-05	9.81e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALB—liver cancer	1.51e-05	9.73e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP1A1—liver cancer	1.47e-05	9.44e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CB—liver cancer	1.47e-05	9.42e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MTHFR—liver cancer	1.37e-05	8.8e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CB—liver cancer	1.35e-05	8.66e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PPARA—liver cancer	1.34e-05	8.63e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CB—liver cancer	1.34e-05	8.59e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CG—liver cancer	1.15e-05	7.39e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PPARG—liver cancer	1.11e-05	7.13e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CD—liver cancer	1.01e-05	6.5e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALB—liver cancer	9.99e-06	6.41e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CA—liver cancer	8.94e-06	5.74e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CB—liver cancer	8.82e-06	5.66e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CA—liver cancer	8.23e-06	5.28e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CA—liver cancer	8.15e-06	5.24e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—AKT1—liver cancer	7.31e-06	4.69e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—AKT1—liver cancer	6.72e-06	4.31e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—AKT1—liver cancer	6.66e-06	4.28e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CA—liver cancer	5.38e-06	3.45e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—AKT1—liver cancer	4.39e-06	2.82e-05	CbGpPWpGaD
